Skin Elements Limited (ASX:SKN)
Australia · Delayed Price · Currency is AUD 0.0030
0.00 (0.00%)
Sep 3, 2026, 8:07 AM AEST
Skin Elements Balance Sheet
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
Assets
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Cash & Equivalents | 0.84 | 0.06 | 0.12 | 0.36 | 0.75 |
Cash & Short-Term Investments | 0.84 | 0.06 | 0.12 | 0.36 | 0.75 |
Cash Growth | 1307.42% | -48.16% | -67.90% | -52.08% | 160.07% |
Accounts Receivable | 0.01 | 0.02 | 0.03 | 0.55 | 1.07 |
Other Receivables | 0.47 | 0.64 | 1.23 | 1.16 | 0.28 |
Receivables | 0.47 | 0.65 | 1.26 | 1.71 | 1.36 |
Inventory | 0 | 0.01 | 0.06 | 0.14 | 0.24 |
Prepaid Expenses | - | - | - | - | 0.5 |
Total Current Assets | 1.32 | 0.72 | 1.43 | 2.21 | 2.85 |
Property, Plant & Equipment | - | 0 | 0.01 | 0.01 | 0.02 |
Other Intangible Assets | - | - | - | - | 7.89 |
Other Long-Term Assets | - | - | - | - | 0.34 |
Total Assets | 1.32 | 0.72 | 1.44 | 2.22 | 11.1 |
Liabilities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Accounts Payable | 0.07 | 0.42 | 0.31 | 0.23 | 0.19 |
Accrued Expenses | -0.02 | 1.69 | 1.95 | 0.73 | 0.46 |
Short-Term Debt | 0.3 | 0.43 | 0.72 | 0.54 | - |
Current Portion of Leases | 0 | 0.01 | 0.01 | 0.02 | 0.02 |
Other Current Liabilities | 0.09 | 0.11 | 0.08 | 0.1 | 0.15 |
Total Current Liabilities | 0.45 | 2.66 | 3.08 | 1.62 | 0.82 |
Other Long-Term Liabilities | - | - | - | - | 0.23 |
Total Liabilities | 0.45 | 2.66 | 3.08 | 1.62 | 1.05 |
Shareholders' Equity
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Common Stock | 32.65 | 25.87 | 24.44 | 24.24 | 22.87 |
Retained Earnings | -33.08 | -28.14 | -26.41 | -24.46 | -13.05 |
Comprehensive Income & Other | 1.3 | 0.34 | 0.34 | 0.82 | 0.23 |
Shareholders' Equity | 0.87 | -1.94 | -1.63 | 0.6 | 10.05 |
Total Liabilities & Equity | 1.32 | 0.72 | 1.44 | 2.22 | 11.1 |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Total Debt | 0.3 | 0.44 | 0.73 | 0.56 | 0.02 |
Net Cash (Debt) | 0.54 | -0.38 | -0.62 | -0.2 | 0.72 |
Net Cash Growth | - | - | - | - | 181.92% |
Net Cash Per Share | 0.00 | -0.00 | -0.00 | -0.00 | 0.00 |
Filing Date Shares Outstanding | 3,141 | 1,050 | 563.99 | 543.99 | 407.73 |
Total Common Shares Outstanding | 3,141 | 1,050 | 563.99 | 543.99 | 407.73 |
Working Capital | 0.87 | -1.94 | -1.64 | 0.59 | 2.03 |
Book Value Per Share | 0.00 | -0.00 | -0.00 | 0.00 | 0.02 |
Tangible Book Value | 0.87 | -1.94 | -1.63 | 0.6 | 2.16 |
Tangible Book Value Per Share | 0.00 | -0.00 | -0.00 | 0.00 | 0.01 |